Skye Bioscience (SKYE) Stock Price
Skye Bioscience Price
For Skye Bioscience, the net margin of -35.4% is down versus 27.8% a few years ago.
Skye Bioscience stock price
Skye Bioscience business model & stock analysis
Frequently asked questions about Skye Bioscience
12 analysts currently rate the Skye Bioscience stock: 9 recommend buying, 3 holding and 0 selling.
Converted at the current exchange rate, the Skye Bioscience share trades at 1.47 EUR (1.65 USD).
The revenue cannot currently be calculated for Skye Bioscience.
The expected profit of Skye Bioscience is -161.58 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Skye Bioscience is currently -0.05. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Skye Bioscience stock.
The P/S cannot be calculated for Skye Bioscience currently.
The Eulerpool Quality Score for Skye Bioscience is 1/10.
The ISIN of Skye Bioscience is US83086J2006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Skye Bioscience is SKYE. The ticker symbol is used to trade Skye Bioscience shares on the stock exchange.
Skye Bioscience stock
Skye Bioscience Peer Group
Skye Bioscience FIGI
All fundamentals and in-depth analysis of Skye Bioscience
Our stock analysis for Skye Bioscience stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Skye Bioscience. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.